APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nucleic Acid Nanotechnology

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nucleic Acid Nanotechnology Market Outlook and Growth Opportunities 2026

5 June 2026198 pages

Choose your research edition.

Industry ResearchNucleic Acid Nanotechnology Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Nucleic Acid Nanotechnology Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Nucleic Acid Nanotechnology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nucleic Acid Nanotechnology Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Nucleic Acid Nanotechnology Market Analysis and Forecast 2026-2032189 pages · $4,950 USD

Market perspective

The global Nucleic Acid Nanotechnology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nucleic Acid Nanotechnology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nucleic Acid Nanotechnology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nucleic Acid Nanotechnology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nucleic Acid Nanotechnology market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nucleic Acid Nanotechnology market include GATTAQUANT GMBH, NuProbe, Genisphere, Nanovery, Esya Labs, Nomic,, Torus Biosystems, NanoApps Medical, Inc. and Creative Biolabs, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Nucleic Acid Nanotechnology market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nucleic Acid Nanotechnology and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nucleic Acid Nanotechnology revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Nucleic Acid Nanotechnology market.

Nucleic Acid Nanotechnology Segment by Company

GATTAQUANT GMBH

NuProbe

Genisphere

Nanovery

Esya Labs

Nomic,

Torus Biosystems

NanoApps Medical, Inc.

Creative Biolabs

tilibit nanosystems

Nucleic Acid Nanotechnology Segment by Type

DNA Nanotechnology

RNA Nanotechnology

Nucleic Acid Nanotechnology Segment by Application

Drug Delivery Systems

Biosensors

Nanorobotics

Other

Nucleic Acid Nanotechnology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nucleic Acid Nanotechnology status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Nucleic Acid Nanotechnology key companies, revenue, market share, and recent developments.

3. To split the Nucleic Acid Nanotechnology breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Nucleic Acid Nanotechnology market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nucleic Acid Nanotechnology significant trends, drivers, influence factors in global and regions.

6. To analyze Nucleic Acid Nanotechnology competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nucleic Acid Nanotechnology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nucleic Acid Nanotechnology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nucleic Acid Nanotechnology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nucleic Acid Nanotechnology industry.

Chapter 3: Detailed analysis of Nucleic Acid Nanotechnology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Nucleic Acid Nanotechnology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Nucleic Acid Nanotechnology in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nucleic Acid Nanotechnology Industry Trends Table 2. Nucleic Acid Nanotechnology Industry Drivers Table 3. Nucleic Acid Nanotechnology Industry Opportunities and Challenges Table 4. Nucleic Acid Nanotechnology Industry Restraints Table 5. Global Nucleic Acid Nanotechnology Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nucleic Acid Nanotechnology Revenue Share by Company (2021-2026) Table 7. Global Nucleic Acid Nanotechnology Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Nucleic Acid Nanotechnology Key Company Manufacturing Base & Headquarters Table 9. Global Nucleic Acid Nanotechnology Company, Product Type & Application Table 10. Global Nucleic Acid Nanotechnology Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Nucleic Acid Nanotechnology by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of DNA Nanotechnology Table 15. Significant Companies of RNA Nanotechnology Table 16. Global Nucleic Acid Nanotechnology Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Nucleic Acid Nanotechnology Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Nucleic Acid Nanotechnology Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Nucleic Acid Nanotechnology Sales Value Share by Type (2021-2026) Table 20. Global Nucleic Acid Nanotechnology Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Drug Delivery Systems Table 22. Significant Companies of Biosensors Table 23. Significant Companies of Nanorobotics Table 24. Significant Companies of Other Table 25. Global Nucleic Acid Nanotechnology Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Nucleic Acid Nanotechnology Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Nucleic Acid Nanotechnology Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Nucleic Acid Nanotechnology Sales Value Share by Application (2021-2026) Table 29. Global Nucleic Acid Nanotechnology Sales Value Share by Application (2027-2032) Table 30. Global Nucleic Acid Nanotechnology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Nucleic Acid Nanotechnology Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Nucleic Acid Nanotechnology Sales Value Share by Region (2021-2026) Table 33. Global Nucleic Acid Nanotechnology Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Nucleic Acid Nanotechnology Sales Value Share by Region (2027-2032) Table 35. Global Nucleic Acid Nanotechnology Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Nucleic Acid Nanotechnology Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Nucleic Acid Nanotechnology Sales Value Market Share by Country (2021-2026) Table 38. Global Nucleic Acid Nanotechnology Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Nucleic Acid Nanotechnology Sales Value Market Share by Country (2027-2032) Table 40. GATTAQUANT GMBH Company Information Table 41. GATTAQUANT GMBH Business Overview Table 42. GATTAQUANT GMBH Nucleic Acid Nanotechnology Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. GATTAQUANT GMBH Nucleic Acid Nanotechnology Product Portfolio Table 44. GATTAQUANT GMBH Recent Development Table 45. NuProbe Company Information Table 46. NuProbe Business Overview Table 47. NuProbe Nucleic Acid Nanotechnology Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. NuProbe Nucleic Acid Nanotechnology Product Portfolio Table 49. NuProbe Recent Development Table 50. Genisphere Company Information Table 51. Genisphere Business Overview Table 52. Genisphere Nucleic Acid Nanotechnology Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Genisphere Nucleic Acid Nanotechnology Product Portfolio Table 54. Genisphere Recent Development Table 55. Nanovery Company Information Table 56. Nanovery Business Overview Table 57. Nanovery Nucleic Acid Nanotechnology Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Nanovery Nucleic Acid Nanotechnology Product Portfolio Table 59. Nanovery Recent Development Table 60. Esya Labs Company Information Table 61. Esya Labs Business Overview Table 62. Esya Labs Nucleic Acid Nanotechnology Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Esya Labs Nucleic Acid Nanotechnology Product Portfolio Table 64. Esya Labs Recent Development Table 65. Nomic, Company Information Table 66. Nomic, Business Overview Table 67. Nomic, Nucleic Acid Nanotechnology Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Nomic, Nucleic Acid Nanotechnology Product Portfolio Table 69. Nomic, Recent Development Table 70. Torus Biosystems Company Information Table 71. Torus Biosystems Business Overview Table 72. Torus Biosystems Nucleic Acid Nanotechnology Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Torus Biosystems Nucleic Acid Nanotechnology Product Portfolio Table 74. Torus Biosystems Recent Development Table 75. NanoApps Medical, Inc. Company Information Table 76. NanoApps Medical, Inc. Business Overview Table 77. NanoApps Medical, Inc. Nucleic Acid Nanotechnology Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. NanoApps Medical, Inc. Nucleic Acid Nanotechnology Product Portfolio Table 79. NanoApps Medical, Inc. Recent Development Table 80. Creative Biolabs Company Information Table 81. Creative Biolabs Business Overview Table 82. Creative Biolabs Nucleic Acid Nanotechnology Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Creative Biolabs Nucleic Acid Nanotechnology Product Portfolio Table 84. Creative Biolabs Recent Development Table 85. tilibit nanosystems Company Information Table 86. tilibit nanosystems Business Overview Table 87. tilibit nanosystems Nucleic Acid Nanotechnology Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. tilibit nanosystems Nucleic Acid Nanotechnology Product Portfolio Table 89. tilibit nanosystems Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Nucleic Acid Nanotechnology Product Image Figure 2. Global Nucleic Acid Nanotechnology Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nucleic Acid Nanotechnology Market Size (2021-2032) & (US$ Million) Figure 4. Global Nucleic Acid Nanotechnology Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. DNA Nanotechnology Image Figure 8. RNA Nanotechnology Image Figure 9. Global Nucleic Acid Nanotechnology Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Nucleic Acid Nanotechnology Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Nucleic Acid Nanotechnology Sales Value Share by Type (2021-2032) Figure 12. Drug Delivery Systems Image Figure 13. Biosensors Image Figure 14. Nanorobotics Image Figure 15. Other Image Figure 16. Global Nucleic Acid Nanotechnology Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Nucleic Acid Nanotechnology Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Nucleic Acid Nanotechnology Sales Value Share by Application (2021-2032) Figure 19. Global Nucleic Acid Nanotechnology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Nucleic Acid Nanotechnology Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Nucleic Acid Nanotechnology Sales Value (2021-2032) & (US$ Million) Figure 22. North America Nucleic Acid Nanotechnology Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Nucleic Acid Nanotechnology Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Nucleic Acid Nanotechnology Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Nucleic Acid Nanotechnology Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Nucleic Acid Nanotechnology Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Nucleic Acid Nanotechnology Sales Value (2021-2032) & (US$ Million) Figure 28. South America Nucleic Acid Nanotechnology Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Nucleic Acid Nanotechnology Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Nucleic Acid Nanotechnology Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • DNA Nanotechnology
  • RNA Nanotechnology
Applications
  • Drug Delivery Systems
  • Biosensors
  • Nanorobotics
  • Other
Companies covered
  • GATTAQUANT GMBH
  • NuProbe
  • Genisphere
  • Nanovery
  • Esya Labs
  • Nomic,
  • Torus Biosystems
  • NanoApps Medical, Inc.
  • Creative Biolabs
  • tilibit nanosystems

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nucleic Acid Nanotechnology Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nucleic Acid Nanotechnology Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Nucleic Acid Nanotechnology Market Dynamics
  1. 2.1 Nucleic Acid Nanotechnology Industry Trends
  2. 2.2 Nucleic Acid Nanotechnology Industry Drivers
  3. 2.3 Nucleic Acid Nanotechnology Industry Opportunities and Challenges
  4. 2.4 Nucleic Acid Nanotechnology Industry Restraints
3 Nucleic Acid Nanotechnology Market by Company
  1. 3.1 Global Nucleic Acid Nanotechnology Company Revenue Ranking in 2025
  2. 3.2 Global Nucleic Acid Nanotechnology Revenue by Company (2021-2026)
  3. 3.3 Global Nucleic Acid Nanotechnology Company Ranking (2024-2026)
  4. 3.4 Global Nucleic Acid Nanotechnology Company Manufacturing Base and Headquarters
  5. 3.5 Global Nucleic Acid Nanotechnology Company Product Type and Application
  6. 3.6 Global Nucleic Acid Nanotechnology Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Nucleic Acid Nanotechnology Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Nucleic Acid Nanotechnology Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Nucleic Acid Nanotechnology Market by Type
  1. 4.1 Nucleic Acid Nanotechnology Type Introduction
  2. 4.1.1 DNA Nanotechnology
  3. 4.1.2 RNA Nanotechnology
  4. 4.2 Global Nucleic Acid Nanotechnology Sales Value by Type
  5. 4.2.1 Global Nucleic Acid Nanotechnology Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nucleic Acid Nanotechnology Sales Value by Type (2021-2032)
  7. 4.2.3 Global Nucleic Acid Nanotechnology Sales Value Share by Type (2021-2032)
5 Nucleic Acid Nanotechnology Market by Application
  1. 5.1 Nucleic Acid Nanotechnology Application Introduction
  2. 5.1.1 Drug Delivery Systems
  3. 5.1.2 Biosensors
  4. 5.1.3 Nanorobotics
  5. 5.1.4 Other
  6. 5.2 Global Nucleic Acid Nanotechnology Sales Value by Application
  7. 5.2.1 Global Nucleic Acid Nanotechnology Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Nucleic Acid Nanotechnology Sales Value by Application (2021-2032)
  9. 5.2.3 Global Nucleic Acid Nanotechnology Sales Value Share by Application (2021-2032)
6 Nucleic Acid Nanotechnology Regional Value Analysis
  1. 6.1 Global Nucleic Acid Nanotechnology Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nucleic Acid Nanotechnology Sales Value by Region (2021-2032)
  3. 6.2.1 Global Nucleic Acid Nanotechnology Sales Value by Region: 2021-2026
  4. 6.2.2 Global Nucleic Acid Nanotechnology Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nucleic Acid Nanotechnology Sales Value (2021-2032)
  7. 6.3.2 North America Nucleic Acid Nanotechnology Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Nucleic Acid Nanotechnology Sales Value (2021-2032)
  10. 6.4.2 Europe Nucleic Acid Nanotechnology Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Nucleic Acid Nanotechnology Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Nucleic Acid Nanotechnology Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Nucleic Acid Nanotechnology Sales Value (2021-2032)
  16. 6.6.2 South America Nucleic Acid Nanotechnology Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Nucleic Acid Nanotechnology Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Nucleic Acid Nanotechnology Sales Value Share by Country, 2025 VS 2032
7 Nucleic Acid Nanotechnology Country-level Value Analysis
  1. 7.1 Global Nucleic Acid Nanotechnology Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nucleic Acid Nanotechnology Sales Value by Country (2021-2032)
  3. 7.2.1 Global Nucleic Acid Nanotechnology Sales Value by Country (2021-2026)
  4. 7.2.2 Global Nucleic Acid Nanotechnology Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Nucleic Acid Nanotechnology Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Nucleic Acid Nanotechnology Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Nucleic Acid Nanotechnology Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GATTAQUANT GMBH
  2. 8.1.1 GATTAQUANT GMBH Company Information
  3. 8.1.2 GATTAQUANT GMBH Business Overview
  4. 8.1.3 GATTAQUANT GMBH Nucleic Acid Nanotechnology Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GATTAQUANT GMBH Nucleic Acid Nanotechnology Product Portfolio
  6. 8.1.5 GATTAQUANT GMBH Recent Developments
  7. 8.2 NuProbe
  8. 8.2.1 NuProbe Company Information
  9. 8.2.2 NuProbe Business Overview
  10. 8.2.3 NuProbe Nucleic Acid Nanotechnology Revenue and Gross Margin (2021-2026)
  11. 8.2.4 NuProbe Nucleic Acid Nanotechnology Product Portfolio
  12. 8.2.5 NuProbe Recent Developments
  13. 8.3 Genisphere
  14. 8.3.1 Genisphere Company Information
  15. 8.3.2 Genisphere Business Overview
  16. 8.3.3 Genisphere Nucleic Acid Nanotechnology Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Genisphere Nucleic Acid Nanotechnology Product Portfolio
  18. 8.3.5 Genisphere Recent Developments
  19. 8.4 Nanovery
  20. 8.4.1 Nanovery Company Information
  21. 8.4.2 Nanovery Business Overview
  22. 8.4.3 Nanovery Nucleic Acid Nanotechnology Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nanovery Nucleic Acid Nanotechnology Product Portfolio
  24. 8.4.5 Nanovery Recent Developments
  25. 8.5 Esya Labs
  26. 8.5.1 Esya Labs Company Information
  27. 8.5.2 Esya Labs Business Overview
  28. 8.5.3 Esya Labs Nucleic Acid Nanotechnology Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Esya Labs Nucleic Acid Nanotechnology Product Portfolio
  30. 8.5.5 Esya Labs Recent Developments
  31. 8.6 Nomic,
  32. 8.6.1 Nomic, Company Information
  33. 8.6.2 Nomic, Business Overview
  34. 8.6.3 Nomic, Nucleic Acid Nanotechnology Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Nomic, Nucleic Acid Nanotechnology Product Portfolio
  36. 8.6.5 Nomic, Recent Developments
  37. 8.7 Torus Biosystems
  38. 8.7.1 Torus Biosystems Company Information
  39. 8.7.2 Torus Biosystems Business Overview
  40. 8.7.3 Torus Biosystems Nucleic Acid Nanotechnology Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Torus Biosystems Nucleic Acid Nanotechnology Product Portfolio
  42. 8.7.5 Torus Biosystems Recent Developments
  43. 8.8 NanoApps Medical, Inc.
  44. 8.8.1 NanoApps Medical, Inc. Company Information
  45. 8.8.2 NanoApps Medical, Inc. Business Overview
  46. 8.8.3 NanoApps Medical, Inc. Nucleic Acid Nanotechnology Revenue and Gross Margin (2021-2026)
  47. 8.8.4 NanoApps Medical, Inc. Nucleic Acid Nanotechnology Product Portfolio
  48. 8.8.5 NanoApps Medical, Inc. Recent Developments
  49. 8.9 Creative Biolabs
  50. 8.9.1 Creative Biolabs Company Information
  51. 8.9.2 Creative Biolabs Business Overview
  52. 8.9.3 Creative Biolabs Nucleic Acid Nanotechnology Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Creative Biolabs Nucleic Acid Nanotechnology Product Portfolio
  54. 8.9.5 Creative Biolabs Recent Developments
  55. 8.10 tilibit nanosystems
  56. 8.10.1 tilibit nanosystems Company Information
  57. 8.10.2 tilibit nanosystems Business Overview
  58. 8.10.3 tilibit nanosystems Nucleic Acid Nanotechnology Revenue and Gross Margin (2021-2026)
  59. 8.10.4 tilibit nanosystems Nucleic Acid Nanotechnology Product Portfolio
  60. 8.10.5 tilibit nanosystems Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst